메뉴 건너뛰기




Volumn 47, Issue 9, 2008, Pages 1438-

Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT;

EID: 50949123940     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken250     Document Type: Note
Times cited : (4)

References (3)
  • 1
    • 38649093636 scopus 로고    scopus 로고
    • Use of parenteral methotrexate significantly reduces the need for biological therapy
    • Bharadwaj A, Agrawal S, Batley M, Hammond A. Use of parenteral methotrexate significantly reduces the need for biological therapy. Rheumatology 2008;47:222.
    • (2008) Rheumatology , vol.47 , pp. 222
    • Bharadwaj, A.1    Agrawal, S.2    Batley, M.3    Hammond, A.4
  • 3
    • 38149057526 scopus 로고    scopus 로고
    • Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis
    • Braun J, Kastner P, Flaxenberg P et al. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis. Arthritis Rheum 2008;58:73-81.
    • (2008) Arthritis Rheum , vol.58 , pp. 73-81
    • Braun, J.1    Kastner, P.2    Flaxenberg, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.